Article References
mRNA COVID-19 Vaccines: Advantages, risks, and unanswered questions
Abbasi, Jennifer. “COVID-19 and MRNA Vaccines—First Large Test for a New Approach.” JAMA, vol. 324, no. 12, Sept. 2020, p. 1125. DOI.org (Crossref), doi:10.1001/jama.2020.16866.
Bjerregaard, B., et al. “Syncytin-1 and Its Receptor Is Present in Human Gametes.” Journal of Assisted Reproduction and Genetics, vol. 31, no. 5, May 2014, pp. 533–39. PubMed Central, doi:10.1007/s10815-014-0224-1.
Corman et al. – 2020 – Detection of 2019 Novel Coronavirus (2019-NCoV) by.Pdf. https://2020news.de/wp-content/uploads/2020/12/Wodarg_Yeadon_EMA_Petition_Pfizer_Trial_FINAL_01DEC2020_EN_unsigned_with_Exhibits.pdf. Accessed 8 Dec. 2020.
Corman, Victor M., et al. “Detection of 2019 Novel Coronavirus (2019-NCoV) by Real-Time RT-PCR.” Eurosurveillance, vol. 25, no. 3, Jan. 2020. DOI.org (Crossref), doi:10.2807/1560-7917.ES.2020.25.3.2000045. Could COVID-19 MRNA Vaccines Cause Autoimmune Diseases? Nov. 2020, p. m4347. —. Nov. 2020, p. m4347.
Jackson, Lisa A., et al. “An MRNA Vaccine against SARS-CoV-2 — Preliminary Report.” New England Journal of Medicine, vol. 383, no. 20, Massachusetts Medical Society, Nov. 2020, pp. 1920–31. Taylor and Francis+NEJM, doi:10.1056/NEJMoa2022483.
Smout, Alistair. “UK Warns People with Serious Allergies to Avoid Pfizer Vaccine after Two Adverse Reactions.” Reuters, 9 Dec. 2020. www.reuters.com, https://www.reuters.com/article/health-coronavirus-britain-vaccine-idUSKBN28J1D1.
World, Republic. “Four Trial Volunteers of Pfizer’s COVID-19 Vaccine Develop Bell’s Palsy, US FDA Clarifies.” Republic World, https://m.republicworld.com/world-news/uk-news/four-trial-volunteers-of-pfizers-covid-19-vaccine-develop-bells-palsy-us-fda-clarifies.html. Accessed 9 Dec. 2020.